STAND Community Trial
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 11 - 17 |
| Updated: | 2/10/2018 |
| Start Date: | May 2015 |
| End Date: | April 2019 |
| Contact: | Margaret H Sibley, Ph.D. |
| Email: | msibley@fiu.edu |
| Phone: | 3053483005 |
Effectiveness of MI Enhanced Behavior Therapy for Adolescents With ADHD
The proposed study evaluates the effectiveness of a family-based psychosocial treatment
program for teens with ADHD (Supporting Teens' Academic Needs Daily; STAND) developed to be
delivered in community settings. STAND is BT enhanced by Motivational Interviewing (MI) that
was developed (R34 MH092466) for teens with ADHD through a stakeholder informed process.
STAND consists of ten 50-minute sessions delivered by therapists with community-typical
levels of training and supervision. Across randomized controlled pilot (N=28; N=36) and
efficacy trials (N=128), STAND demonstrates medium to large effects on ADHD and ODD symptoms
and indices of academic and family impairment. In the proposed study, 240 adolescents with
ADHD who present for treatment at one of four community mental health agencies in Miami-Dade
County, FL will be randomly assigned to STAND or agency usual care (UC). Participating agency
therapists also will be randomly assigned to deliver STAND or UC. STAND therapists will
receive a comprehensive treatment manual, three-day training, and weekly supervision from a
project psychologist. Participants will be screened by research staff in the community
setting and enrolled on a rolling basis over 30 months. Participants will be assessed at
baseline, post-treatment, and three-month follow-up. In line with RDoC, multi-method measures
will be obtained for treatment outcome (family and academic impairment), treatment mediators
(executive functioning, parent academic involvement, parent-teen communication,
parent/adolescent motivation, ADHD symptoms), and moderators of effectiveness (patient,
practitioner, service delivery, and organization characteristics). Additional consumer
perspective (satisfaction, therapeutic alliance) and agency fit (therapist competence,
treatment fidelity, need for additional treatment, attendance, therapist attitude toward
treatment, cost effectiveness) measures will also be obtained to evaluate effectiveness. We
will recruit an ethnically diverse sample (65% Hispanic, 19% African-American, 16%
Non-Hispanic White) that is historically underrepresented in research, but ideal for
evaluating therapy effectiveness.
program for teens with ADHD (Supporting Teens' Academic Needs Daily; STAND) developed to be
delivered in community settings. STAND is BT enhanced by Motivational Interviewing (MI) that
was developed (R34 MH092466) for teens with ADHD through a stakeholder informed process.
STAND consists of ten 50-minute sessions delivered by therapists with community-typical
levels of training and supervision. Across randomized controlled pilot (N=28; N=36) and
efficacy trials (N=128), STAND demonstrates medium to large effects on ADHD and ODD symptoms
and indices of academic and family impairment. In the proposed study, 240 adolescents with
ADHD who present for treatment at one of four community mental health agencies in Miami-Dade
County, FL will be randomly assigned to STAND or agency usual care (UC). Participating agency
therapists also will be randomly assigned to deliver STAND or UC. STAND therapists will
receive a comprehensive treatment manual, three-day training, and weekly supervision from a
project psychologist. Participants will be screened by research staff in the community
setting and enrolled on a rolling basis over 30 months. Participants will be assessed at
baseline, post-treatment, and three-month follow-up. In line with RDoC, multi-method measures
will be obtained for treatment outcome (family and academic impairment), treatment mediators
(executive functioning, parent academic involvement, parent-teen communication,
parent/adolescent motivation, ADHD symptoms), and moderators of effectiveness (patient,
practitioner, service delivery, and organization characteristics). Additional consumer
perspective (satisfaction, therapeutic alliance) and agency fit (therapist competence,
treatment fidelity, need for additional treatment, attendance, therapist attitude toward
treatment, cost effectiveness) measures will also be obtained to evaluate effectiveness. We
will recruit an ethnically diverse sample (65% Hispanic, 19% African-American, 16%
Non-Hispanic White) that is historically underrepresented in research, but ideal for
evaluating therapy effectiveness.
Inclusion Criteria:
- ADHD diagnosis
- IQ of at least 70
- Enrollment in sixth through twelfth grade
Exclusion Criteria:
- history of autism spectrum disorder
- not attending a Miami-Dade County Public School
- a primary presenting problem other than ADHD, requiring immediate treatment of a
different domain
We found this trial at
1
site
1001 Washington Avenue
Miami, Florida 33139
Miami, Florida 33139
Principal Investigator: Margaret H Sibley, Ph.D.
Phone: 305-348-8312
Click here to add this to my saved trials
